Ridgewood NJ, as previously reported on Wednesday the Council introduced a resolution that would prohibit “all classes of cannabis establishments, distributors and delivery services, including cultivators, manufacturers, wholesalers, retailers, cannabis testing facilities, medical cannabis dispensaries, clinical registrant or cannabis retailer, including alternative treatment centers.” A public hearing on the proposed ordinance is set for June 9.
Technology has changed almost everything, including how we print. Before then, printing was just in plain paper, black and white color. The technology then changed to 2-dimensions before recently evolving to 3D. 3D printing has become a game-changer since it has led to printing so many things, which seemed impossible to many. It lets you print the full object in height, length, and even width. Manufacturers are being used to create a replacement for their machines and other amazing things, as discussed in this article. Here is the list of these things.
“People who are terminally ill should not have to go from country to country to seek a cure — I want to give them a chance right here at home.”
President Donald J. Trump
May 31,2018
the staff of the Ridgewood blog
Washington DC , in a historic move and another campaign promise met Congress passed the Right to Try Act of 2017, sending a priority bill to President Donald J. Trump for his signature.
The “Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Belllina Right to Try Act of 2017” passed Congress on May 22, 2018.
The bill amends Federal law to allow certain unapproved, experimental drugs to be administered to terminally ill patients who have exhausted all approved treatment options and are unable to participate in clinical drug trials.
Eligible drugs must have undergone the Food and Drug Administration’s (FDA) Phase I (safety) testing.
The bill requires any manufacturer or sponsor of an eligible investigational drug to report to the FDA on any use of the drug on a “Right to Try” basis.
The FDA will post an annual summary report of “Right to Try” use on its website.
The bill limits the liability of drug sponsors, manufacturers, prescribers, or dispensers that provide or decline to provide an eligible investigational drug to an eligible patient.
A RIGHT TO LIFE: Right to try legislation returns treatment decisions back to patients, giving them the right to make healthcare choices that could save their lives.
“Right to Try” gives the over 1 million Americans who die from a terminal illness every year a new tool to fight and make potentially lifesaving decisions about their treatment.
According to the National Cancer Institute, an estimated 609,640 Americans will die from cancer alone in 2018.
Prior to this legislation, options for terminally patients who had exhausted all treatment options were extremely limited:
Many terminally ill patients were considered too sick for clinical trials of new medication. In fact, only 3 percent of cancer patients today are enrolled in clinical trials.
The FDA’s “compassionate use” application is complicated and time-consuming, resulting in only about 1,200 approved applications per year.
With President Trump’s signature the Federal government joins with 40 States that have approved the right of terminally ill patients to try potentially lifesaving drugs.
MAKING HEALTHCARE WORK FOR AMERICANS: Every day, President Trump is working to fix America’s broken healthcare system and return healthcare decisions to individuals.
On May 11, 2018, the President issued his blueprint to lower prescription drug prices, taking action to put American patients first.
President Trump has signed multiple Executive Orders and approved new funding to target the scourge of opioid abuse and is taking the fight to drug abuse across the Nation.
In March 2018, President Trump’s Administration released the President’s plan to put patients back in charge of their own health information.
President Trump is putting healthcare decisions back into the hands of Americans by repealing Obamacare’s individual mandate, ending the healthcare rationing board, and providing more affordable options outside of Obamacare.
As Manufacturers Meet President Trump to Talk Regulations, Taxes and Infrastructure, Industry Is More Confident in Improving Business Climate
by Jennifer Drogus
March 31, 2017
Washington, D.C., Fresh off the heels of the third straight month of manufacturing job growth, the National Association of Manufacturers (NAM) today released the first Manufacturers’ Outlook Survey since President Donald Trump took office. The survey shows a dramatic shift in sentiment, with more than 93 percent of manufacturers feeling positive about their economic outlook. This is the highest in the survey’s 20-year history, up from 56.6 percent one year ago and 77.8 percent in December.
The NAM’s release of the survey coincided with a meeting of small and medium-sized manufacturers at the White House today.
“Across America, manufacturers’ optimism is soaring, in no small part because of President Trump’s laser-like focus on pursuing bold action, particularly on rethinking red tape to address regulatory reform, to accelerate a jobs surge in America,” said NAM President and CEO Jay Timmons.
“As the survey shows, manufacturers of all sizes are now less concerned about the business climate going forward because they are counting on President Trump to deliver results. Small manufacturers—more than 90 percent of our membership—are among the hardest hit by regulatory obstacles. Regulatory costs for small manufacturers with fewer than 50 employees total almost $35,000 per employee per year—money that could otherwise go to creating jobs. It’s encouraging to see an administration so focused on providing regulatory relief to spur manufacturing growth.
“We are grateful for the chance to meet with the president today as we continue to tell the White House directly which regulations are still the biggest obstacles to a manufacturing surge. There is much work to be done, and manufacturers have the solutions on regulatory reform as well as on infrastructure investment, workforce development, bold comprehensive tax reform and a host of other issues.”
The survey shows not only a positive outlook but also that concerns about the business environment have dropped. When manufacturers were asked to identify top challenges to their business, concerns about the business environment fell to third place. This had previously been respondents’ top concern since the question was added to the survey in 2011.
For the past 20 years, the NAM has surveyed its membership of more than 14,000 large and small manufacturers to gain insight into their economic outlook, hiring and investment decisions and business concerns. The NAM releases these results to the public each quarter.
